Editor's Note Hospitals with high volumes of surgical aortic valve replacements (SAVRs) are more likely to be fast adopters of transcatheter aortic valve replacement procedures (TAVRs), and accumulating SAVR and TAVR caseloads is associated with better survival after TAVR, this study finds. Using Medicare data on 60,538 TAVR procedures performed…

Read More

Editor's Note The Food & Drug Administration on November 2 identified the recall by Maquet Datascope Corp/Getinge Group’s Cardiosave Hybrid and Cardiosave Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because of the potential for the autofill process to malfunction or fail during…

Read More

Editor's Note The Joint Commission on October 24 announced that beginning January 1, 2019, any hospital wanting to pursue the Advanced Certification in Heart Failure or Comprehensive Cardiac Center Certification will no longer have to be accredited by the Joint Commission. The Joint Commission says it is making this change…

Read More

Editor's Note The Joint Commission and the American Heart Association (AHA) will offer a single cardiovascular (CV) certification program for hospitals beginning January 1, 2019, the Joint Commission announced on October 10. The single certification is designed to enhance CV patient care and improve outcomes and quality of life. It…

Read More

Editor's Note The Perioperative Surgical Home (PSH) model of care was successful in improving quality of care and outcomes in elderly hip fracture patients and children having cardiac surgery in two studies presented October 14 at the Anesthesiology 2018 annual meeting in San Francisco. One study compared 308 hip fracture…

Read More

Editor's Note In cardiac surgery patients at moderate-to-high risk for death, a restrictive strategy for red blood cell (RBC) transfusion was equivalent to a liberal strategy, with respect to death from any cause, myocardial infarction, stroke, or renal failure, at 6-months follow-up, this study finds. There also were no significant…

Read More

Editor' Note The Joint Commission in partnership with the American Heart Association recently approved a new certification program that will provide an independent evaluation of an organization's eligibility to qualify as a comprehensive cardiac center. After reviewing program requirements, the Joint Commission identified the following areas for revision: Collaborative model…

Read More

Editor's Note The Food and Drug Administration (FDA) on September 30 posted an announcement by Getinge that it is voluntarily initiating a worldwide recall involving a field correction of some 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp. The recall is because of the potential for interruption…

Read More

Editor's Note The Food & Drug Administration (FDA) on August 17 issued a Safety Alert for SynCardia Systems’ (Tucson, Arizona) Temporary Total Artificial Heart Companion 2 Driver System. Final results from a post-approval study indicate higher mortality and stroke rates for patients initially supported with the C2 Driver System compared…

Read More

Editor's Note The Joint Commission and American Heart Association (AHA) on July 25 announced a new jointly offered hospital cardiovascular certification program. The “Advanced Certification for Heart Failure” program is the first of multiple, jointly offered cardiac certifications that will be available to hospitals. Organizations must meet the following criteria:…

Read More